default author photo

Haiyang Hu

Shenyang Pharmaceutical University

Shenyang

China

  • Shenyang Pharmaceutical University

SCHOLARLY PAPERS

2

DOWNLOADS

164

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Self-Amplifying ROS Sensitive Prodrug Based Nanodecoys Circumventing Immune Resistance for Chemotherapy-Sensitized Immunotherapy

Number of pages: 30 Posted: 26 Feb 2022
Jiulong Zhang, Xiaoyan Sun, Mengdan Xu, Xiufeng Zhao, Chunrong Yang, Kexin Li, Fan Zhao, Haiyang Hu, Mingxi Qiao, Dawei Chen and Xiuli Zhao
Shenyang Pharmaceutical University, Shenyang Pharmaceutical University - School of Pharmacy, Shenyang Pharmaceutical University, Affiliated Hongqi Hospital of Mudanjiang Medical College - Department of Oncology, Jiamusi University - School of Pharmacy, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University - School of Pharmacy, Shenyang Pharmaceutical University and Shenyang Pharmaceutical University - School of Pharmacy
Downloads 83 (790,029)

Abstract:

Loading...

self-amplifying, cancer immunotherapy, prodrug nanoparticles, tumor immunosuppressive microenvironment, tumor-associated macrophage, colony-stimulating factor 1

2.

Immunogenic Cell Death Amplified by Blockage of IDO1 Pathway Based on Charge-Switchable Nanoparticles for Elevated Cancer Immunotherapy

Number of pages: 35 Posted: 14 Apr 2022
Menghao Shi, Jiulong Zhang, Yu Wang, Yanyan Han, Xiuli Zhao, Haiyang Hu, Mingxi Qiao and Dawei Chen
Shenyang Pharmaceutical University - Department of Pharmaceutics, Shenyang Pharmaceutical University - Department of Pharmaceutics, Shenyang Pharmaceutical University - Department of Pharmaceutics, Shenyang Pharmaceutical University - Department of Pharmaceutics, Shenyang Pharmaceutical University - School of Pharmacy, Shenyang Pharmaceutical University, Shenyang Pharmaceutical University - School of Pharmacy and Shenyang Pharmaceutical University
Downloads 81 (803,225)

Abstract:

Loading...

Cancer immunotherapy, indoleamine 2, 3-dioxygenase 1, immunosuppressive tumor microenvironment, mitoxantrone, immunogenic cell death.